Literature DB >> 24114635

What causes alzheimer's disease?

R A Armstrong1.   

Abstract

Since the earliest descriptions of Alzheimer's disease (AD), many theories have been advanced as to its cause. These include: (1) exacerbation of aging, (2) degeneration of anatomical pathways, including the cholinergic and cortico-cortical pathways, (3) an environmental factor such as exposure to aluminium, head injury, or malnutrition, (4) genetic factors including mutations of amyloid precursor protein (APP) and presenilin (PSEN) genes and allelic variation in apolipoprotein E (Apo E), (5) mitochondrial dysfunction, (6) a compromised blood brain barrier, (7) immune system dysfunction, and (8) infectious agents. This review discusses the evidence for and against each of these theories and concludes that AD is a multifactorial disorder in which genetic and environmental risk factors interact to increase the rate of normal aging ('allostatic load'). The consequent degeneration of neurons and blood vessels results in the formation of abnormally aggregated 'reactive' proteins such as β-amyloid (Aβ) and tau. Gene mutations influence the outcome of age-related neuronal degeneration to cause early onset familial AD (EO-FAD). Where gene mutations are absent and a combination of risk factors present, Aβ and tau only slowly accumulate not overwhelming cellular protection systems until later in life causing late-onset sporadic AD (LO-SAD). Aβ and tau spread through the brain via cell to cell transfer along anatomical pathways, variation in the pathways of spread leading to the disease heterogeneity characteristic of AD.

Entities:  

Mesh:

Year:  2013        PMID: 24114635     DOI: 10.5114/fn.2013.37702

Source DB:  PubMed          Journal:  Folia Neuropathol        ISSN: 1509-572X            Impact factor:   2.038


  42 in total

1.  Characterization of circRNA-Associated-ceRNA Networks in a Senescence-Accelerated Mouse Prone 8 Brain.

Authors:  Shuai Zhang; Dina Zhu; Hong Li; Hejian Li; Chengqiang Feng; Wensheng Zhang
Journal:  Mol Ther       Date:  2017-06-29       Impact factor: 11.454

Review 2.  Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide and its soluble salts.

Authors:  Calvin C Willhite; Nataliya A Karyakina; Robert A Yokel; Nagarajkumar Yenugadhati; Thomas M Wisniewski; Ian M F Arnold; Franco Momoli; Daniel Krewski
Journal:  Crit Rev Toxicol       Date:  2014-10       Impact factor: 5.635

Review 3.  Brain Under Stress and Alzheimer's Disease.

Authors:  Boris Mravec; Lubica Horvathova; Alexandra Padova
Journal:  Cell Mol Neurobiol       Date:  2017-07-11       Impact factor: 5.046

4.  Glio-vascular changes during ageing in wild-type and Alzheimer's disease-like APP/PS1 mice.

Authors:  C S Janota; D Brites; C A Lemere; M A Brito
Journal:  Brain Res       Date:  2015-05-09       Impact factor: 3.252

5.  Association of BDNF and BCHE with Alzheimer's disease: Meta-analysis based on 56 genetic case-control studies of 12,563 cases and 12,622 controls.

Authors:  Huihui Ji; Dongjun Dai; Yunliang Wang; Danjie Jiang; Xingyu Zhou; Peipei Lin; Xiaosui Ji; Jinfeng Li; Yuzheng Zhang; Honglei Yin; Rongrong Chen; Lina Zhang; Mingqing Xu; Shiwei Duan; Qinwen Wang
Journal:  Exp Ther Med       Date:  2015-03-03       Impact factor: 2.447

6.  Glutathione S-transferases variants as risk factors in Alzheimer's disease.

Authors:  Tengfei Wang
Journal:  Neurol Sci       Date:  2015-05-17       Impact factor: 3.307

7.  Sex Differences in Innate Immune Response of Peripheral Blood Leukocytes of Alzheimer's Disease Patients.

Authors:  Marta Sochocka; Michał Ochnik; Maciej Sobczyński; Beata Orzechowska; Jerzy Leszek
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2022-06-16       Impact factor: 4.291

Review 8.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

9.  Gene Therapy Models of Alzheimer's Disease and Other Dementias.

Authors:  Benjamin Combs; Andrew Kneynsberg; Nicholas M Kanaan
Journal:  Methods Mol Biol       Date:  2016

Review 10.  Endo-lysosomal pathway and ubiquitin-proteasome system dysfunction in Alzheimer's disease pathogenesis.

Authors:  Jiqing Cao; Margaret B Zhong; Carlos A Toro; Larry Zhang; Dongming Cai
Journal:  Neurosci Lett       Date:  2019-03-16       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.